© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Mid Market Top 50 – Proton Partners
Posted 9th June 2016

Mid Market Top 50 – Proton Partners

Proton Partners International Ltd is a company formed by UK based and international cancer and healthcare specialists.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Mid Market Top 50 – Proton Partners
Image

Mid Market Top 50 – Proton Partners

Proton Partners International Ltd is a company formed by UK based and international cancer and healthcare specialists. As it stands there are currently no high-energy operational Proton Beam Therapy facilities in the UK, however there is a growing need for more specialised care. Proton Partners aims to build three Proton Beam Therapy centres across the UK. Below, the company sets out how it aims to revolutionise the treatment of cancer in UK.

Proton Partners believe that cancer patients deserve the best possible care without needing to leave the country or spending huge amounts of money and therefore we want to make sure that Proton Beam Therapy is a treatment that is available on a suitable scale within the UK.

Simply speaking, Proton Beam Therapy is a type of radiotherapy used in cancer treatment, delivering heavily charged protons in a more targeted manner to reduce damage to peripheral tissue and organs. Protons deliver the same damage to cancer cells as traditional radiotherapy, however they can be controlled to stop at a defined point in the body. The sharp cut off that means Proton Beam Therapy is a much more targeted form of treatment, compared to traditional radiotherapy, which lowers long-term side effects significantly.

In the UK, there are more than 150,000 cancer patients treated with traditional radiotherapy every year, however it is estimated that at least 10% of these patients could be better treated with Proton Beam Therapy. Our services will be available to NHS patients from England, Scotland and Wales, as well as medically-insured private patients and self-paying patients with each centre having the capacity to treat up to 500 unique patients a year. The three centres will provide an all-encompassing cancer service for patients, comprising of radiotherapy, chemotherapy and diagnostics. 

Our plan is to network the three centres together into an eco-system to help advance Proton Beam Therapy technology from a patient perspective, rather than a manufacturers perspective, and develop greater outcomes for patients. Ultimately, the spirt of our centres is to beat cancer. This therapy is not a panacea but it does make a real difference for patients and will help to revolutionise the level of care that is currently available in UK.

Looking beyond the UK, the global incidence of cancer is soaring due to rapidly ageing populations in most countries. By 2020, it is expected that there will be 20 million new cancer patients each year, 70% of whom will live in countries that have less than 5% of the necessary resources for cancer treatment. Globally, there are currently 44 operational Proton Beam Therapy facilities, which between them have treated over 95,000 people. Dutch, French, Italian and Swedish studies show that between 10% and 20% of patients receiving radiotherapy would in fact be better off with Proton Beam Therapy.

This level of demand would mean a requirement for 18 centres in UK, far more than the two currently planned by the NHS. Most European countries are now planning for at least 10% of radiotherapy to be delivered by protons.

Over 1,000 clinical studies are in progress and it is likely that further data on long-term toxicity will support a major expansion in this area. If the UK does not make the right decisions today, we will again fall behind in the quality of treatment we will be able to offer cancer patients in the future.

In terms of our background, the company was formed in 2015 following discussions between Professor Karol Sikora, former head of the World Health Organisation’s cancer programme, Mike Moran, who has held various executive positions in defence and healthcare in the UK and abroad, Professor Sir Chris Evans, the leading life sciences entrepreneur, and Neil Woodford, founding partner of Woodford Investment Management.

The Wales Life Sciences Investment Fund, established by the Welsh Government and operated by Arthurian Life Sciences, has invested in Proton Partners and has been instrumental in establishing the first centre in the UK, which will be based in Newport, Wales. To date, Proton Partners has received almost £100million backing from the Welsh Government and UK investors.

With over 30 years of experience in strategic planning and leadership, Proton Partners Chief Executive Officer Mike Moran has been successful in leading the company from strength to strength. Prominent oncologist Professor Karol Sikora has been appointed Chief Medical Director, and Professor Gordon McVie and Mike von Bertele have both been appointed non-executive Chairman and non-executive Director respectively.

However, it is not just a few individuals who are behind our success, but all of our people can take tremendous pride in our results so far. At all levels of Proton Partners, our team is committed to ensuring that Proton Beam Therapy has an integral role to play in the future of UK’s battle against cancer.

Looking towards the latter half of 2016 and beyond, the biggest challenge for us is the acceptance of Proton Beam Therapy among oncologists in the UK. Their referrals will get patients into our centres. Building upon the UK’s reputation for clinical excellence, and through our existing academic affiliations, our centres will be at the forefront of Proton Beam Therapy research, using patient experience to inform oncologists and drive the improvements in technology.

Company: Proton Partners International Ltd
Name: Liz Richards
Email: Liz.Richards@ proton-int.com
Web: www.proton-int.com
Address: Proton Partners
International Ltd, Life Sciences
Hub Wales, 3 Assembly Square,
Cardiff, CF10 4PL
Phone: +44 (0) 1633 810 661




Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
Easing the Strains of Relocation
Finance
31/08/2016Easing the Strains of Relocation

Permit Pro provides specialised immigration services for expatriates and their family who plan to work and live in Malaysia.

Read Full PostRead - Eye Icon
Fatigue Management Policies: How To Craft Effective Guidelines For Fleet Safety
Corporate Social Responsibility
14/12/2023Fatigue Management Policies: How To Craft Effective Guidelines For Fleet Safety

In the demanding world of fleet management, ensuring the safety and well-being of drivers is paramount. Fatigue, an often-underestimated hazard, poses significant risks to the drivers, public safety, and the company's reputation.

Read Full PostRead - Eye Icon
3 Proven Strategies for Mastering the Art of Closing High-Stake M&A Deals
M&A
31/05/20233 Proven Strategies for Mastering the Art of Closing High-Stake M&A Deals

Mergers and acquisitions have always been risky undertakings that can end without profit. The most complex transactions can rightfully involve M&A that can drag on for years without any visible results.

Read Full PostRead - Eye Icon
The Best in IP
Legal
29/09/2016The Best in IP

Founded in 1937 as a Patent and Trademarks Agency, Sena & Berton Moreno has grown to reach a workforce of forty people offering a range of services to its clients today.

Read Full PostRead - Eye Icon
Freetech Wins Bid
M&A
17/10/2016Freetech Wins Bid

A leading asphalt pavement maintenance integrated solution provider, announced that the Group's major subsidiary won a bid on bulk equipment procurement project with Hainan Province Highway Department and will provide 13 sets of asphalt pavement multi-purpFree

Read Full PostRead - Eye Icon
How to Hire Your First Employee for a Small Business: 6 Important Steps
Corporate Social Responsibility
12/06/2023How to Hire Your First Employee for a Small Business: 6 Important Steps

The excitement of hiring your first employee is something you’ll probably remember for years to come. But this step is also a giant leap of faith you need to take for your small business to move forward.

Read Full PostRead - Eye Icon
HAYSTACKID Acquisition of FLEX Discovery Transaction
Innovation
29/02/2016HAYSTACKID Acquisition of FLEX Discovery Transaction

HAYSTACKID is an international end-to-end eDiscovery and forensics services and solutions provider.

Read Full PostRead - Eye Icon
Privée At The Pinnacle
Innovation
Read Full PostRead - Eye Icon
Why Custom Awards Play a Crucial Role in Employee Motivation
News
09/05/2024Why Custom Awards Play a Crucial Role in Employee Motivation

Every business strives to unlock the secret to employee motivation, understanding that a motivated team is the engine behind any successful venture. Enter the world of custom awards, a method proven to recognize individual achievements and fuel a dedicated wor



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow